Company Filing History:
2 out of 2 
1 out of 20 
1 out of 1,168 Years Active: 2011-2023
Title: Arik Hasson: Innovator in Pancreatic Cell Research
Introduction
Arik Hasson, based in Kiryat-Ono, Israel, is a notable inventor known for his contributions to the field of biotechnology and regenerative medicine. With three patents to his name, Hasson's work primarily focuses on methods for producing and purifying pancreatic endocrine cells from pluripotent stem cells.
Latest Patents
Hasson's latest patents include innovative methods for differentiating and purifying pancreatic endocrine cells. One such patent describes processes involving compositions and methods that utilize cell surface markers specifically for pluripotent-derived pancreatic endoderm-type cells. Another patent highlights a method for generating insulin-producing islet cells from pluripotent stem cells. This process includes a series of culturing steps involving differentiation mediums and growth factors to transform stem cells into functional islet cells, showcasing the potential for advancements in diabetes treatment.
Career Highlights
Throughout his career, Arik Hasson has made significant strides in the biotechnology sector. He has worked with prominent organizations such as Kadimastem Ltd. and Gamida Cell Ltd., where he has developed groundbreaking techniques that enhance the understanding and capabilities of cell differentiation and regeneration.
Collaborations
Hasson has collaborated with distinguished professionals in his field, including Michel Revel and Kfir Molakandov. These partnerships have enriched his research endeavors, leading to innovative discoveries and furthering advancements in the field of regenerative medicine.
Conclusion
Arik Hasson's contributions to pancreatic cell research reflect a dedication to pushing the boundaries of science and medicine. His patents not only represent his expertise but also indicate a promising future for the application of these innovative methods in treating diabetes and other related conditions. As research advances, Hasson's work will likely play a crucial role in improving therapeutic options and patient outcomes in the biomedical field.